Department of Anaesthesiology and Pain Medicine, Chonnam National University Medical School, Gwangju, South Korea.
Acta Anaesthesiol Scand. 2012 Jul;56(6):770-6. doi: 10.1111/j.1399-6576.2011.02640.x. Epub 2012 Jan 31.
Dose requirements of thiopental depend on patient characteristics and infusion rate. We determined thiopental dose requirements for induction of anaesthesia, and the effects of remifentanil on cardiovascular and bispectral index (BIS) responses to tracheal intubation in spinal cord-injured (SCI) patients undergoing general anaesthesia.
Twenty patients with traumatic complete SCI undergoing elective surgery were enrolled. Twenty patients without SCI served as control. Anaesthesia was induced with thiopental, followed by remifentanil 1 μg/kg and rocuronium 0.8 mg/kg, and maintained with 2% sevoflurane and 50% nitrous oxide in oxygen after tracheal intubation. Thiopental was administered at a rate of 50 mg/15 s until abolition of the eyelash reflex. Thiopental doses, BIS values, systolic arterial blood pressure (SAP), heart rate (HR) and plasma catecholamine concentrations were measured.
Total thiopental dose required to abolish the eyelash reflex based on total body weight (BW) (5.26 ± 0.87 vs. 3.91 ± 1.07 mg/kg, P < 0.001) or lean BW (6.56 ± 1.37 vs. 5.24 ± 1.36 mg/kg, P < 0.01) were significantly smaller in the SCI group than in the control. SAP was decreased by induction of anaesthesia with thiopental and remifentanil, and increased by tracheal intubation in both groups. However, the peak SAP after intubation was smaller in the SCI patients. HR increased significantly above baseline values following intubation in both groups with no significant intergroup differences. Hypertension was more frequent in the control group. Norepinephrine concentrations remained unaltered following intubation in both groups.
These results suggest that the dose requirements of thiopental for induction of general anaesthesia and subsequent tracheal intubation are reduced in the SCI patients.
硫喷妥钠的剂量需求取决于患者特征和输注率。我们确定了硫喷妥钠诱导麻醉的剂量需求,以及瑞芬太尼对脊髓损伤(SCI)患者全身麻醉下气管插管时心血管和脑电双频指数(BIS)反应的影响。
纳入 20 例择期手术的外伤性完全性 SCI 患者。20 例无 SCI 的患者作为对照组。麻醉诱导用硫喷妥钠,继以瑞芬太尼 1μg/kg 和罗库溴铵 0.8mg/kg,气管插管后用 2%七氟醚和 50%氧化亚氮维持麻醉。给予硫喷妥钠 50mg/15s,直至睫毛反射消失。测量硫喷妥钠剂量、BIS 值、收缩压(SAP)、心率(HR)和血浆儿茶酚胺浓度。
根据总体重(BW)(5.26±0.87 vs. 3.91±1.07mg/kg,P<0.001)或去脂体重(6.56±1.37 vs. 5.24±1.36mg/kg,P<0.01),SCI 组完全性脊髓损伤患者需要的总硫喷妥钠剂量来消除睫毛反射显著小于对照组。诱导麻醉用硫喷妥钠和瑞芬太尼后 SAP 降低,两组气管插管后 SAP 升高。然而,SCI 患者插管后的 SAP 峰值较低。两组患者插管后 HR 均明显高于基线值,但组间无显著差异。对照组高血压更常见。两组患者插管后去甲肾上腺素浓度均无变化。
这些结果表明,脊髓损伤患者全身麻醉诱导和随后气管插管时硫喷妥钠的剂量需求降低。